190 related articles for article (PubMed ID: 34545159)
1. Structural basis for small molecule targeting of Doublecortin Like Kinase 1 with DCLK1-IN-1.
Patel O; Roy MJ; Kropp A; Hardy JM; Dai W; Lucet IS
Commun Biol; 2021 Sep; 4(1):1105. PubMed ID: 34545159
[TBL] [Abstract][Full Text] [Related]
2. Autoregulatory control of microtubule binding in doublecortin-like kinase 1.
Agulto RL; Rogers MM; Tan TC; Ramkumar A; Downing AM; Bodin H; Castro J; Nowakowski DW; Ori-McKenney KM
Elife; 2021 Jul; 10():. PubMed ID: 34310279
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of doublecortin-like kinase 1 inhibitors and their bioactivity evaluation.
Pan P; Ji D; Li Z; Meng X
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2287990. PubMed ID: 38062554
[TBL] [Abstract][Full Text] [Related]
4. Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1.
Weygant N; Qu D; Berry WL; May R; Chandrakesan P; Owen DB; Sureban SM; Ali N; Janknecht R; Houchen CW
Mol Cancer; 2014 May; 13():103. PubMed ID: 24885928
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Landscape and Therapeutic Implication of Gene Isoforms of Doublecortin-Like Kinase 1 for Cancer Stem Cells.
Moore LL; Houchen CW
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003596
[TBL] [Abstract][Full Text] [Related]
6. DCLK1 and its oncogenic functions: A promising therapeutic target for cancers.
Ye L; Liu B; Huang J; Zhao X; Wang Y; Xu Y; Wang S
Life Sci; 2024 Jan; 336():122294. PubMed ID: 38007147
[TBL] [Abstract][Full Text] [Related]
7. Targeting Doublecortin-Like Kinase 1 (DCLK1)-Regulated SARS-CoV-2 Pathogenesis in COVID-19.
Undi RB; Larabee JL; Filiberti A; Ulahannan S; Aravindan S; Stroberg E; Barton LM; Duval EJ; Mukhopadhyay S; Henthorn JC; Akins D; Houchen CW; Huycke MM; Ali N
J Virol; 2022 Sep; 96(17):e0096722. PubMed ID: 35943255
[TBL] [Abstract][Full Text] [Related]
8. Spatial and temporal diversity of DCLK1 isoforms in developing mouse brain.
Bergoglio E; Suzuki IK; Togashi K; Tsuji M; Takeuchi S; Koizumi H; Emoto K
Neurosci Res; 2021 Sep; 170():154-165. PubMed ID: 33485913
[TBL] [Abstract][Full Text] [Related]
9. Research Progress of DCLK1 Inhibitors as Cancer Therapeutics.
Cheng L; Huang S; Chen L; Dong X; Zhang L; Wu C; Ye K; Shao F; Zhu Z; Thorne RF
Curr Med Chem; 2022; 29(13):2261-2273. PubMed ID: 34254905
[TBL] [Abstract][Full Text] [Related]
10. Doublecortin-Like Kinase 1 Facilitates Dendritic Spine Growth of Pyramidal Neurons in Mouse Prefrontal Cortex.
Murphy KE; Zhang EY; Wyatt EV; Sperringer JE; Duncan BW; Maness PF
Neuroscience; 2023 Jan; 508():98-109. PubMed ID: 36064052
[TBL] [Abstract][Full Text] [Related]
11. DCLK1 Suppresses Tumor-Specific Cytotoxic T Lymphocyte Function Through Recruitment of MDSCs via the CXCL1-CXCR2 Axis.
Yan R; Li J; Xiao Z; Fan X; Liu H; Xu Y; Sun R; Liu J; Yao J; An G; Shi Y; Ge Y
Cell Mol Gastroenterol Hepatol; 2023; 15(2):463-485. PubMed ID: 36309200
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a doublecortin-like kinase 1 inhibitor to prevent inflammatory responses in acute lung injury.
Cai B; Xu Y; Luo R; Lu K; Wang Y; Zheng L; Zhang Y; Yin L; Tu L; Luo W; Zheng L; Zhang F; Lv X; Tang Q; Liang G; Chen L
Bioorg Chem; 2024 Apr; 145():107215. PubMed ID: 38394920
[TBL] [Abstract][Full Text] [Related]
13. Molecular Mechanism of Mutational Disruption of DCLK1 Autoinhibition Provides a Rationale for Inhibitor Screening.
Chen W; Liu R; Yu Y; Wei D; Chen Q; Xu Q
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762326
[TBL] [Abstract][Full Text] [Related]
14. DCLK1 phosphorylates the microtubule-associated protein MAP7D1 to promote axon elongation in cortical neurons.
Koizumi H; Fujioka H; Togashi K; Thompson J; Yates JR; Gleeson JG; Emoto K
Dev Neurobiol; 2017 Apr; 77(4):493-510. PubMed ID: 27503845
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and Structural Insights into Doublecortin-like Kinase Domain 1.
Patel O; Dai W; Mentzel M; Griffin MD; Serindoux J; Gay Y; Fischer S; Sterle S; Kropp A; Burns CJ; Ernst M; Buchert M; Lucet IS
Structure; 2016 Sep; 24(9):1550-61. PubMed ID: 27545623
[TBL] [Abstract][Full Text] [Related]
16. Blocking of doublecortin-like kinase 1-regulated SARS-CoV-2 replication cycle restores cell signaling network.
Undi RB; Ahsan N; Larabee JL; Darlene-Reuter N; Papin J; Dogra S; Hannafon BN; Bronze MS; Houchen CW; Huycke MM; Ali N
J Virol; 2023 Nov; 97(11):e0119423. PubMed ID: 37861336
[TBL] [Abstract][Full Text] [Related]
17. Structural Basis of Inhibition of DCLK1 by Ruxolitinib.
Jang DM; Lim HJ; Hahn H; Lee Y; Kim HK; Kim HS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445192
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic expression of DCLK1-S, a novel DCLK1 isoform, is associated with tumor aggressiveness and worse disease-specific survival in colorectal cancer.
Kalantari E; Ghods R; Saeednejad Zanjani L; Rahimi M; Eini L; Razmi M; Asadi-Lari M; Madjd Z
Cancer Biomark; 2022; 33(3):277-289. PubMed ID: 34958000
[TBL] [Abstract][Full Text] [Related]
19. Expression of alternatively spliced variants of the Dclk1 gene is regulated by psychotropic drugs.
Zygmunt M; Hoinkis D; Hajto J; Piechota M; Skupień-Rabian B; Jankowska U; Kędracka-Krok S; Rodriguez Parkitna J; Korostyński M
BMC Neurosci; 2018 Sep; 19(1):55. PubMed ID: 30208879
[TBL] [Abstract][Full Text] [Related]
20. Chemical Biology Toolkit for DCLK1 Reveals Connection to RNA Processing.
Liu Y; Ferguson FM; Li L; Kuljanin M; Mills CE; Subramanian K; Harshbarger W; Gondi S; Wang J; Sorger PK; Mancias JD; Gray NS; Westover KD
Cell Chem Biol; 2020 Oct; 27(10):1229-1240.e4. PubMed ID: 32755567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
